FrancophonIA/ELRC3.0 huggingface dataset:
English: With the other hand, twist the orange connector to remove.
Croatian: Drugom rukom odvrnite narančasti priključak kako biste ga odvojili.
English: Remember: You must take your injection of Bydureon immediately after mixing it.
Croatian: Zapamtite: Bydureon morate injicirati odmah nakon što ste ga pomiješali.
English: In two studies prolonged-release exenatide 2 mg once weekly has been compared to immediate-release exenatide 5 mcg given twice daily for 4 weeks followed by immediate-release exenatide 10 mcg given twice daily.
Croatian: U dva je ispitivanja eksenatid s produljenim oslobađanjem u dozi od 2 mg jednom tjedno uspoređivan s primjenom eksenatida s trenutnim oslobađanjem u dozi od 5 µg dvaput dnevno tijekom 4 tjedna, nakon čega je slijedila primjena eksenatida s trenutnim oslobađanjem u dozi od 10 µg dvaput dnevno.
English: A clinically relevant effect of prolonged-release exenatide and immediate-release exenatide treated subjects was observed on HbA1c, regardless of the background anti-diabetic therapy in both studies.
Croatian: Klinički značajan učinak na HbA1c eksenatida s produljenim oslobađanjem i eksenatida s trenutnim oslobađanjem opažen je kod liječenih ispitanika u oba ispitivanja bez obzira na osnovnu antidijabetičku terapiju.
English: Now, pick up the vial with the orange connector attached.
Croatian: Sada uzmite bočicu s pričvršćenim narančastim priključkom.
English: Now, hold the vial so the syringe is pointing up.
Croatian: Sada držite bočicu tako da je štrcaljka okrenuta prema gore.
English: Prolonged-release suspension for injection in pre-filled pen (BCise).
Croatian: Suspenzija za injekciju s produljenim oslobađanjem u napunjenoj brizgalici (BCise).
English: Mean HbA1c (%)
Croatian: Srednja vrijednost HbA1c (%)
English: In the placebo-controlled study with insulin glargine, the change from baseline to Week 28 in fasting plasma glucose was -0.7 mmol/l for the prolonged-release exenatide group and -0.1 mmol/l for the placebo group.
Croatian: U placebom kontroliranom ispitivanju s inzulinom glarginom, promjena od početne vrijednosti do 28. tjedna u glukozi u plazmi natašte bila je -0,7 mmol/l za skupinu liječenu eksenatidom s produljenim oslobađanjem, i -0,1 mmol/l za skupinu koja je uzimala placebo.
English: The concurrent use of prolonged-release exenatide with D-phenylalanine derivatives (meglitinides), alpha-glucosidase inhibitors, dipeptidyl peptidase-4 inhibitors or other GLP-1 receptor agonists has not been studied.
Croatian: Nije ispitivana istodobna primjena eksenatida s produljenim oslobađanjem s derivatima D-fenilalanina (meglitinidima), inhibitorima alfa-glukozidaze, inhibitorima dipeptidil peptidaze-4 ili drugim agonistima GLP-1 receptora.
English: A mean increase in heart rate (HR) of 2.6 beats per minute (bpm) from baseline (74 bpm) was observed in pooled prolonged-release exenatide clinical studies.
Croatian: Srednje povećanje srčane frekvencije od 2,6 otkucaja po minuti od početne vrijednosti (74 otkucaja po minuti) je bilo primijećeno u objedinjenim kliničkim studijama eksenatida s produljenim oslobađanjem.
English: Clinical experience in patients with moderate renal impairment (creatinine clearance 30 to 50 ml/min) is limited (see section 5.2).
Croatian: Kliničko je iskustvo u bolesnika s umjerenim oštećenjem bubrega (klirens kreatinina 30 do 50 ml/min) oskudno (vidjeti dio 5.2).
English: D. Inject the medicine.
Croatian: Injicirajte lijek.
English: Rare side effects • feeling jittery
Croatian: Rijetke nuspojave • osjećaj nervoze
English: See Description of selected adverse reactions section, below.
Croatian: Vidjeti „Opis odabranih nuspojava“ u nastavku.
English: if needed.
Croatian: OD LIJEKA, AKO JE POTREBNO
English: How to use Bydureon pre-filled pen
Croatian: Kako koristiti Bydureon napunjenu brizgalicu
English: The concurrent use of prolonged-release exenatide formulations with D-phenylalanine derivatives (meglitinides), alpha-glucosidase inhibitors, dipeptidyl peptidase-4 inhibitors or other GLP-1 receptor agonists has not been studied.
Croatian: Nije ispitivana istodobna primjena formulacija eksenatida s produljenim oslobađanjem s derivatima D-fenilalanina (meglitinidima), inhibitorima alfa-glukozidaze, inhibitorima dipeptidil peptidaze-4 ili drugim agonistima GLP-1 receptora.
English: Rate based on twelve prolonged-release exenatide completed long-term efficacy and safety studies n=2868 total (patients on sulphonylurea n=1002).
Croatian: Stopa na temelju podataka iz 12 dovršenih dugoročnih ispitivanja sigurnosti i djelotvornosti eksenatida s produljenim oslobađanjem n=2868 ukupno (bolesnici na sulfonilureji n=1002).
English: The suspension is packaged in a 2-ml Type I glass cartridge, sealed at one end with a (bromobutyl) rubber seal/cap combination (combiseal), and at the other end with a (bromobuty) rubber plunger.
Croatian: Suspenzija dolazi u staklenom ulošku (staklo tipa I) volumena 2 ml, koji je s jedne strane zatvoren kombiniranim (brombutilnim) gumenim zatvaračem, a s druge (brombutilnim) gumenim klipom.
English: Part of a multi-pack of 3 x (4 single dose kits).
Croatian: Dio višestrukog pakiranja od 3 x (4 jednodozna seta).
English: A reduction in systolic blood pressure was observed in the 4 comparator-controlled prolonged-release exenatide studies (2.9 mmHg to 4.7 mmHg).
Croatian: U 4 ispitivanja eksenatida s produljenim oslobađanjem kontrolirana usporednim lijekom opaženo je sniženje sistoličkog krvnog tlaka (2,9 mmHg do 4,7 mmHg).
English: Population pharmacokinetic analysis of renal impaired patients receiving 2 mg prolonged-release exenatide indicate that there may be an increase in systemic exposure of approximately 74% and 23% (median prediction in each group) in moderate (N = 10) and mild (N = 56) renal impaired patients, respectively as compared to normal (N = 84) renal function patients.
Croatian: Populacijska farmakokinetička analiza u bolesnika s oštećenjem bubrega koji su primali eksenatid s produljenim oslobađanjem u dozi od 2 mg ukazuju na moguće povećanje sustavne izloženosti od približno 74% u bolesnika s umjerenim (n=10) te približno 23% u bolesnika s blagim oštećenjem bubrega (n=56) (medijan predikcije u svakoj skupini), u usporedbi s bolesnicima (n=84) s normalnom bubrežnom funkcijom.
English: This draws the medicine from the vial into the syringe.
Croatian: Na taj način ćete povući lijek iz bočice u štrcaljku.
English: The effect on beta-cell function was sustained through 52 weeks.
Croatian: Učinak na funkciju beta stanica održao se tijekom 52 tjedna.
English: Prolonged-release exenatide resulted in a statistically significant reduction in HbA1c compared to patients receiving immediate-release exenatide (Table 4).
Croatian: Primjena eksenatida s produljenim oslobađanjem rezultirala je statistički značajnim smanjenjem HbA1c u usporedbi s bolesnicima koji su primali eksenatid s trenutnim oslobađanjem (Tablica 4).
English: Helpful hints
Croatian: Korisni savjeti
English: Cases of inflammation of the pancreas (pancreatitis) have been reported uncommonly (may affect up to 1 in 100 people ) in patients receiving this medicine.
Croatian: Prijavljeni su slučajevi upale gušterače (pankreatitis) sa učestalošću manje često (mogu se javiti u do 1 na 100 osoba) u bolesnika koji su primali ovaj lijek.
English: Prolonged-release suspension for injection 4 single-dose pre-filled pens (BCise) BCise
Croatian: Suspenzija za injekciju s produljenim oslobađanjem 4 jednodozne napunjene brizgalice (BCise) BCise
English: • injection site reactions
Croatian: • reakcije na mjestu injekcije
English: Prolonged-release exenatide resulted in a statistically significant reduction in HbA1c compared to patients receiving immediate-release exenatide (Table 2).
Croatian: Primjena eksenatida s produljenim oslobađanjem rezultirala je statistički značajnim smanjenjem HbA1c u usporedbi s bolesnicima koji su primali eksenatid s trenutnim oslobađanjem (Tablica 2).
English: Keep pushing on the plunger with your thumb until it stops, and hold it in place.
Croatian: Pritišćite klip palcem dok se ne zaustavi i držite ga na mjestu.
English: Each single-dose kit contains one vial of 2 mg exenatide, one pre-filled syringe of 0.65 ml solvent, one vial connector, and two injection needles (one spare).
Croatian: Svaki jednodozni set sadrži jednu bočicu s 2 mg eksenatida, jednu napunjenu štrcaljku s 0,65 ml otapala, jedan priključak za bočicu i dvije igle za injekciju (jedna je rezervna).
English: The clinical experience in patients with moderate renal impairment is limited and the use of prolonged-release exenatide is not recommended.
Croatian: Kliničko je iskustvo u bolesnika s umjerenim oštećenjem bubrega oskudno pa se primjena eksenatida s produljenim oslobađanjem ne preporučuje.
English: by holding the pen against the page.
Croatian: tako što ćete brizgalicu položiti uz papir.
English: Each dose should be administered in the abdomen, thigh, or the back of the upper arm as a subcutaneous injection immediately after suspension of the powder in the solvent.
Croatian: Svaka doza se mora primijeniti supkutanom injekcijom u područje abdomena, bedra ili stražnjeg dijela nadlaktice odmah nakon suspenzije praška u otapalu.
English: Clinically and statistically significantly more subjects on prolonged-release compared to immediate-release exenatide patients achieved an HbA1c reduction of ≤ 7 % or < 7 % in the two studies (p <0.05 and p ≤0.0001, respectively).
Croatian: U ta dva ispitivanja, klinički i statistički značajno više ispitanika na eksenatidu s produljenim oslobađanjem u usporedbi s primjenom eksenatida s trenutnim oslobađanjem postiglo je smanjenje HbA1c na ≤ 7% (p < 0,05) ili < 7% (p < 0,0001).
English: The results of long-term clinical studies of prolonged-release exenatide are presented below; these studies comprised 1356 subjects treated with prolonged-release exenatide, 52% men and 48% women; 230 subjects (17%) were ≥ 65 years of age.
Croatian: Rezultati dugotrajnih kliničkih ispitivanja eksenatida s produljenim oslobađanjem prikazani su u nastavku; ovim je ispitivanjima obuhvaćeno 1356 ispitanika liječenih eksenatidom s produljenim oslobađanjem, od čega 52% muškaraca i 48% žena; 230 ispitanika (17%) je imalo ≥ 65 godina.
English: • Talk with your doctor, pharmacist or diabetes nurse
Croatian: • Obratite se svom liječniku, ljekarniku ili medicinskoj sestri u dijabetološkoj ambulanti
English: Use only the supplied needles with the pen.
Croatian: Smiju se koristiti samo igle isporučene s brizgalicom.
English: Table 3: Results of one 28-week study of Bydureon BCise versus sitagliptin and placebo in combination with metformin (modified intent to treat patients
Croatian: Tablica 3: Rezultati jednog 28-tjednog ispitivanja lijeka Bydureon BCise naspram sitagliptina i placeba u kombinaciji s metforminom (modificirana populacija ispitanika predviđenih za liječenje
English: Prolonged-release suspension for injection Multipack: 12 (3 packs of 4) single-dose pre-filled pens (BCise) BCise
Croatian: Suspenzija za injekciju s produljenim oslobađanjem Višestruko pakiranje: 12 (3 pakiranja s 4) jednodoznih napunjenih brizgalica BCise
English: Prolonged-release exenatide must be injected subcutaneously immediately after mixing of the powder and the solvent.
Croatian: Eksenatid s produljenim oslobađanjem se mora injicirati supkutano odmah nakon miješanja praška i otapala.
English: Remove one pen from the refrigerator and let it stand at room temperature for at least 15 minutes.
Croatian: Izvadite jednu brizgalicu iz hladnjaka i ostavite je na sobnoj temperaturi najmanje 15 minuta.
English: CARTON - 4 SINGLE-DOSE KITS
Croatian: KUTIJA - 4 JEDNODOZNA SETA
English: Multi-pack of 3 x (4 single dose kits).
Croatian: Višestruko pakiranje od 3 x (4 jednodozna seta).
English: Hold the pen up straight with the orange cap toward the ceiling.
Croatian: Držite brizgalicu uspravno, tako da narančasti zatvarač bude usmjeren prema gore.
English: Keep pushing on the plunger with your thumb while shaking.
Croatian: Nastavite pritiskati klip palcem dok tresete.
English: This is to make sure you get the full dose.
Croatian: Tako ćete biti sigurni da ste primijenili cijelu dozu.
English: Therefore, the use of prolonged-release exenatide is not recommended in patients with severe gastrointestinal disease.
Croatian: Stoga se ne preporučuje primjena eksenatida s produljenim oslobađanjem u bolesnika s teškom gastrointestinalnom bolešću.
English: The frequency of adverse reactions of prolonged-release exenatide identified from clinical studies and spontaneous reports (not observed in clinical studies, frequency not known) are summarised in Table 1 below.
Croatian: U Tablici 1 u nastavku sažeto su prikazane učestalosti nuspojava eksenatida s produljenim oslobađanjem prikupljene iz kliničkih ispitivanja i spontanih prijava (nisu zamijećene u kliničkim ispitivanjima, učestalost je nepoznata).
English: Slowly push
Croatian: Lagano potiskujte
English: in either your stomach, thigh, or back of the arm. Each week you can use the same area of your body but choose a different injection site in that area.
Croatian: Svakog tjedna možete injicirati u isti dio tijela, ali odaberite različito mjesto za injiciranje na tom području.
English: Unless a trained person can help to inject this medicine it is not recommended for people who are blind or cannot see well.
Croatian: Ovaj se lijek ne preporučuje slijepim i slabovidnim osobama osim ako za njegovo injiciranje nemaju pomoć druge za to obučene osobe.
English: Each single-dose pre-filled pen is provided with one custom needle.
Croatian: Svaka jednodozna napunjena brizgalica dolazi s jednom prilagođenom iglom.
English: How to store Bydureon
Croatian: Kako čuvati Bydureon
English: Bydureon BCise 2 mg QW
Croatian: Bydureon BCise, 2 mg jednom tjedno
English: • hypoglycaemia (low blood sugar) when this medicine is used with a medicine that does not contain a sulphonylurea
Croatian: • hipoglikemija (niske razine šećera u krvi) kod primjene u kombinaciji s lijekom koji ne sadrži sulfonilureju
English: How to use Bydureon
Croatian: Kako primjenjivati Bydureon
English: D. Choose your injection site.
Croatian: Odaberite mjesto za injiciranje.
English: It may help to hold the pen up to the light to see in the window.
Croatian: Možda ćete bolje vidjeti kroz prozorčić ako brizgalicu usmjerite prema svjetlu.
English: In a 28-week open-label study, Bydureon BCise was compared to immediate-release exenatide in subjects on a diet and exercise programme alone or with a stable regimen of oral glucose-lowering medicinal products.
Croatian: U 28-tjednom otvorenom ispitivanju, lijek Bydureon BCise uspoređivao se s eksenatidom s trenutnim oslobađanjem u bolesnika koji su slijedili program dijete i tjelovježbe, bilo sam ili u kombinaciji sa stabilnim režimom liječenja oralnim lijekovima za snižavanje razine glukoze.
English: A delay in tmax of about 2 h was observed when warfarin was administered 35 min after immediate-release exenatide.
Croatian: Kada se varfarin primjenjivao 35 minuta nakon eksenatida s trenutnim oslobađanjem, opažena je odgoda tmax od oko 2 sata.
English: • hypoglycaemia (low blood sugar) when taken with an insulin
Croatian: • hipoglikemija (niske razine šećera u krvi) kod primjene u kombinaciji s inzulinom
English: There have been spontaneously reported cases of increased INR (International Normalized Ratio), sometimes associated with bleeding, with concomitant use of warfarin and exenatide (see section 4.5).
Croatian: Kod istodobne primjene varfarina i eksenatida spontano su prijavljeni slučajevi povećanja INR-a (međunarodnog normaliziranog omjera), ponekad povezani s krvarenjem (vidjeti dio 4.5).
English: Patients (%) achieving HbA1c ≤7% Mean body weight (kg) Baseline
Croatian: Bolesnici (%) koji su postigli HbA1c ≤ 7% Srednja vrijednost tjelesne težine (kg) Početna vrijednost
English: Prolonged-release exenatide 2 mg
Croatian: Eksenatid s produljenim oslobađanjem 2 mg
English: B. Make sure you received your full dose.
Croatian: Provjerite jeste li primili cijelu dozu.
English: Keep pushing on the plunger with your thumb to keep the plunger in place.
Croatian: I dalje pritišćite klip palcem kako biste ga zadržali na mjestu.
English: Pull the plunger down beyond the black dashed Dose Line.
Croatian: Povucite klip prema dolje, ispod crne isprekidane oznake doze.
English: Slowly push in the plunger so the top of the plunger lines up with the black dashed Dose Line.
Croatian: Polako potiskujte klip dok se njegov gornji rub ne poravna s crnom isprekidanom oznakom doze.
English: Thyroid tumours have been observed in rats and mice with long acting GLP-1 receptor agonists.
Croatian: U štakora i miševa koji su primali dugodjelujuće agoniste GLP-1 receptora opaženi su tumori štitnjače.
English: Be sure to choose a different injection site in that area.
Croatian: Svakako odaberite različito mjesto injekcije na tom dijelu tijela.
English: • WITHOUT twisting the knob, ROTATE the pen every few taps.
Croatian: • OKRENITE brizgalicu nakon svakih nekoliko udaraca, ali NEMOJTE pritom okretati kotačić.
English: The primary safety (noninferiority) and efficacy (superiority) endpoint in EXSCEL was the time to first confirmed Major Adverse Cardiac Event (MACE): cardiovascular (CV)-related death, nonfatal myocardial infarction (MI) or nonfatal stroke.
Croatian: Primarna mjera ishoda za sigurnost (neinferiornost) i djelotvornost (superiornost) u ispitivanju EXSCEL bilo je vrijeme do prvog potvrđenog velikog kardiovaskularnog štetnog događaja (engl.
English: 4 single-dose pre-filled pens
Croatian: 4 jednodozne napunjene brizgalice
English: STEP 2: Mix the medicine
Croatian: 2. KORAK: Promiješajte lijek
English: Mixing window
Croatian: Prozorčić za miješanje
English: The solvent is packaged in a 1.5 ml Type 1 glass pre-filled syringe sealed with a bromobutyl rubber cap and a rubber plunger.
Croatian: Otapalo je pakirano u staklenu napunjenu štrcaljku (staklo tipa I) volumena 1,5 ml, koja je zatvorena čepom od bromobutilne gume i gumenim klipom.
English: Adjusted least squares means (LS Means) and treatment group difference(s) in the change from baseline values at Week 28 are modelled using a mixed model with repeated measures (MMRM) including treatment, region, baseline HbA1c stratum (<9.0% or ≥9.0%), week, and treatment by week interaction as fixed factors, and baseline value as a covariate.
Croatian: Least Squares Means) i razlika(e) među liječenim skupinama u promjeni od početnih vrijednosti u 28. tjednu dobiveni su koristeći mješoviti model s ponovljenim mjerenjima (engl. mixed model with repeated measures) uključujući liječenje, regiju, početni HbA1c stratum (< 9,0% ili ≥ 9,0%), tjedan, i interakciju liječenja po tjednima kao fiksne faktore i početnu vrijednost kao kovarijancu.
English: In a 26-week double-blind study prolonged-release exenatide was compared to maximum daily doses of sitagliptin and pioglitazone in subjects also using metformin.
Croatian: U 26-tjednom dvostruko slijepom ispitivanju eksenatid s produljenim oslobađanjem je uspoređivan s najvišim dnevnim dozama sitagliptina i pioglitazona u ispitanika koji su uzimali i metformin.
English: Follow the instructions for the user to prepare and inject your dose.
Croatian: Za pripremu i injiciranje doze slijedite Upute za korisnika.
English: The patient should be instructed to discard the syringe safely, with the needle still attached after each injection.
Croatian: Bolesnika treba uputiti da nakon svake injekcije štrcaljku zbrine na siguran način, s još uvijek pričvršćenom iglom.
English: What Bydureon BCise pen contains - The active substance is exenatide.
Croatian: Što Bydureon BCise brizgalica sadrži - Djelatna tvar je eksenatid.
English: Insert the needle into your skin (subcutaneously).
Croatian: Zabodite iglu u kožu (potkožno).
English: B. Shake the pen hard, in an up-and-down motion, until the medicine is mixed evenly and you do not see any white medicine along the sides, bottom or top.
Croatian: Žustro protresite brizgalicu, gore-dolje, sve dok lijek ne bude jednoliko pomiješan i dok na stijenkama, dnu ili vrhu prozorčića više ne bude bijelih tragova lijeka.
English: 4 single-dose pre-filled pens.
Croatian: 4 jednodozne napunjene brizgalice.
English: Overall, 9.3% of patients treated with Bydureon BCise reported nausea during the controlled period of both clinical studies.
Croatian: Sveukupno je mučninu tijekom kontroliranog razdoblja obaju kliničkih ispitivanja prijavilo 9,3% bolesnika liječenih lijekom Bydureon BCise.
English: How to Store Bydureon BCise pen
Croatian: Kako čuvati Bydureon BCise brizgalicu
English: After mixing the liquid with the powder, use the suspension only if the mixture is white to off white and cloudy.
Croatian: Nakon miješanja tekućine i praška, suspenziju smijete upotrijebiti samo ako je bijele do bjelkaste boje i mutna.
English: Change in fasting serum glucose (mmol/l) (± SE)
Croatian: Promjena glukoze u plazmi natašte (mmol/l) (± SE)
English: Table 2: Results of one 28-week study of Bydureon BCise versus immediate-release exenatide with diet and exercise alone or with a stable regimen of oral glucose-lowering medicinal products (modified intent to treat patients
Croatian: Tablica 2: Rezultati jednog 28-tjednog ispitivanja lijeka Bydureon BCise naspram eksenatida s trenutnim oslobađanjem u bolesnika koji su slijedili program dijete i tjelovježbe, bilo sam ili u kombinaciji sa stabilnim režimom liječenja oralnim lijekovima za snižavanje razine glukoze (modificirana populacija ispitanika predviđenih za liječenje
English: Bydureon must be injected immediately after mixing.
Croatian: Bydureon se mora injicirati odmah nakon miješanja.
English: Compared with insulin glargine treatment, prolonged-release exenatide demonstrated a superior change in HbA1c, significantly lowered mean body weight and was associated with fewer hypoglycaemic events (Table 5).
Croatian: U usporedbi s inzulinom glarginom, eksenatid s produljenim oslobađanjem pokazao se boljim što se tiče promjene vrijednosti HbA1c, značajno je snizio srednju vrijednost tjelesne težine te je bio povezan s manje hipoglikemijskih događaja (Tablica 5).
English: Do not over tighten.
Croatian: Nemojte prejako stegnuti.
English: Compared with insulin glargine treatment, prolonged-release exenatide demonstrated a superior change in HbA1c, significantly lowered mean body weight and was associated with fewer hypoglycaemic events (Table 3).
Croatian: U usporedbi s inzulinom glarginom, eksenatid s produljenim oslobađanjem pokazao se boljim što se tiče promjene vrijednosti HbA1c, značajno je snizio srednju vrijednost tjelesne težine te je bio povezan s manje hipoglikemijskih događaja (Tablica 3).
English: If you see clumps of dry powder on the sides of the pen, the medicine is NOT mixed well.
Croatian: Ako vidite nakupine suhog praška na stijenkama brizgalice, to znači da lijek NIJE dobro promiješan.
English: Patients switching from immediate-release exenatide (Byetta) to prolonged-release exenatide (Bydureon or Bydureon BCise) may experience transient elevations in blood glucose concentrations, which generally improve within the first four weeks after initiation of therapy.
Croatian: U bolesnika koji prelaze s eksenatida s trenutnim oslobađanjem (Byetta) na eksenatid s produljenim oslobađanjem (Bydureon ili Bydureon BCise) može doći do prolaznog povišenja koncentracija glukoze u krvi, koje se uglavnom poboljša unutar prva četiri tjedna nakon početka terapije.
English: If you see clumps of dry powder on the sides or bottom of the vial, the medicine is NOT mixed well.
Croatian: Ako vidite nakupine suhog praška na stijenkama ili na dnu bočice, to znači da lijek NIJE dobro promiješan.
English: SE = standard error, CI = confidence interval, * p < 0.05
Croatian: SE = standardna pogreška, CI= interval pouzdanosti, * p < 0,05
English: • hypoglycaemia (low blood sugar) when taken with a medicine that contains a sulphonylurea.
Croatian: • hipoglikemija (niske razine šećera u krvi) kod primjene u kombinaciji s lijekom koji sadrži sulfonilureju
English: Rate based on twelve prolonged-release exenatide completed long-term efficacy and safety studies n = 2868 total.
Croatian: Stopa na temelju podataka iz 12 dovršenih dugoročnih ispitivanja sigurnosti i djelotvornosti eksenatida s produljenim oslobađanjem n=2868 ukupno.